蛋白質體學市場規模、佔有率及成長分析（按儀器技術、試劑、服務、軟體、應用、最終用戶和地區）－2025-2032 年產業預測

2023 年蛋白質體學市場規模價值 318 億美元，預計將從 2024 年的 361.6 億美元成長到 2032 年的 1,009.9 億美元，預測期內（2025-2032 年）的複合年成長率為 13.7%。

慢性病的盛行率不斷上升，預計到 2022 年將有 2,000 萬例新發癌症病例，這是蛋白質體學市場成長的主要驅動力。對高效診斷方法日益成長的需求，推動蛋白質體學在藥物開發和研發領域應用的擴展，進一步擴大了市場。蛋白質體學是一門研究生物系統中蛋白質的複雜作用和關係的領域，在識別疾病和發現新的治療方法發揮關鍵作用。透過細緻分析蛋白質的結構、功能以及與 RNA 和 DNA 等其他分子的相互作用，蛋白質體學有助於我們理解複雜的生物過程並推動醫療保健解決方案的發展。因此，蛋白質體學市場在應對緊迫的醫療挑戰的過程中正在經歷強勁成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 專利分析
• 監管分析
• 案例研究
• 客戶和購買標準分析
• 貿易分析

蛋白質體學市場規模（依儀器技術及複合年成長率） (2025-2032)

• 市場概覽
• 光譜學
  • 質譜法
  • 核磁共振波譜
  • 圓二色譜
• 層析法
  • 高效液相層析
  • 離子層析法
  • 親和層析法
  • 超臨界流體層析
• 電泳
  • 凝膠電泳
  • 毛細管電泳
• 蛋白質微陣列
  • 生物晶片
  • 實驗室晶片
  • 蛋白質晶片
  • 微陣列儀器
  • 整合系統
  • 微陣列掃描儀
  • 阿萊耶爾
• X光結晶
• 表面等離子體共振
• 蛋白質分餾
• 其他測量技術

蛋白質體學市場規模（按試劑和複合年成長率） (2025-2032)

• 市場概覽
• 免疫檢測
• 光譜試劑
• 層析法試劑
• 蛋白質微陣列試劑
• X光結晶試劑
• 電泳試劑
• 蛋白質分離試劑
• 其他試劑

蛋白質體學市場規模（依服務及複合年成長率） (2025-2032)

• 市場概覽
• 核心蛋白質體學服務
  • 蛋白質鑑定服務
  • 定量蛋白質體學服務
  • 蛋白質表徵服務
  • 蛋白質精製服務
  • 蛋白質分離服務
  • 蛋白質序列分析服務
  • 自訂檢測服務
• 生物資訊服務

蛋白質體學市場規模（依軟體分類）及複合年成長率（2025-2032）

• 市場概覽
• 生物資訊學工具
• 生物資訊資料庫

蛋白質體學市場規模（按應用分類）及複合年成長率（2025-2032）

• 市場概覽
• 臨床診斷
  • 癌症
  • 感染疾病
  • 糖尿病
  • 神經系統疾病
  • 自體免疫疾病
  • 心血管疾病
  • 其他臨床診斷應用
• 藥物研發
  • 目標發現
  • 線索識別
  • 先導藥物最適化
  • 臨床前研究
• 其他用途

蛋白質體學市場規模（依最終用戶分類）及複合年成長率（2025-2032）

• 市場概覽
• 生物製藥公司
• 學術研究所
• 醫院
• 臨床實驗室
• 其他最終用戶

蛋白質體學市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Thermo Fisher Scientific（USA）
• Agilent Technologies（USA）
• Waters Corporation（USA）
• Bruker Corporation（Germany）
• Danaher Corporation（USA）
• GE Healthcare Life Sciences（UK）
• Bio-Rad Laboratories（USA）
• Shinwa Chemical Industries（Japan）
• Nexelis（Canada）
• Proteome Sciences（UK）
• Kyowa Kirin（Japan）

結論和建議

Proteomics Market size was valued at USD 31.8 billion in 2023 and is poised to grow from USD 36.16 billion in 2024 to USD 100.99 billion by 2032, growing at a CAGR of 13.7% during the forecast period (2025-2032).

The rising incidence of chronic illnesses, including an estimated 20 million new cancer cases in 2022, is significantly propelling the growth of the proteomics market. As the demand for efficient diagnostic methods escalates, the expanding applications of proteomics in drug development and research further enhance this market. Proteomics-a field study focusing on the intricate roles and relationships of proteins within biological systems-plays a crucial role in disease identification and the exploration of novel treatment options. By meticulously analyzing protein structures, functions, and interactions with other molecules such as RNA and DNA, proteomics contributes to understanding complex biological processes and fosters advancements in healthcare solutions. As such, the proteomics market is experiencing robust expansion as it addresses urgent medical challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the Proteomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Proteomics Market Segments Analysis

Global Proteomics Market is segmented by Instrumentation Technology, Reagent, Service, Software, Application, End User and region. Based on Instrumentation Technology, the market is segmented into Spectroscopy,Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, Surface Plasmon Resonance, Protein Fractionation and Other Instrumentation Technologies. Based on Reagent, the market is segmented into Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents, Protein Fractionation Reagents and Other Reagents. Based on Service, the market is segmented into Core Proteomics Services and Bioinformatics Services. Based on Software, the market is segmented into Bioinformatics Tools and Bioinformatics Databases. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development and Other Applications. Based on End User, the market is segmented into Biopharmaceutical Companies, Academic And Research Institutes, Hospitals, Clinical Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Proteomics Market

The proteomics market is primarily driven by significant advancements in technology that have dramatically enhanced sensitivity and resolution. These innovations have not only allowed for high-throughput and multiplexed analyses but also improved data integration and sample preparation methods. Such developments have transformed the understanding of the proteome, leading to a more comprehensive exploration of proteins and their functions. As a result, these breakthroughs have played a pivotal role in stimulating the growth of the proteomics market, paving the way for new applications and research opportunities that capitalize on advanced analytical capabilities.

Restraints in the Proteomics Market

One significant restraint in the proteomics market is the challenge of navigating disparate regulatory frameworks across different countries. The lack of universally accepted standards can complicate the adoption of proteomic technologies, as varying regulations may restrict their implementation. This inconsistency can hinder international collaborations and partnerships, ultimately resulting in prolonged product approval processes. Consequently, the absence of a cohesive regulatory environment creates barriers to market growth, as companies may face delays in launching their innovations and may struggle to meet differing compliance requirements across regions, thus stifling the overall potential of the proteomics industry.

Market Trends of the Proteomics Market

The global proteomics market is experiencing significant growth driven by rapid technological advancements in mass spectrometry and next-generation sequencing. These innovations enhance the sensitivity and accuracy of protein analysis, rendering complex biological processes more comprehensible to researchers. As a result, proteomics has become integral to biomarker discovery, facilitating the identification of specific proteins associated with various diseases. This trend reflects a broader demand for precision medicine, where tailored treatments can be developed based on detailed protein profiles. Consequently, the proteomics market is poised for sustained expansion, appealing to pharmaceutical and diagnostic sectors seeking innovative solutions in disease management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Regulatory Analysis
• Case Studies
• Customer And Buying Criteria Analysis
• Trade Analysis

Global Proteomics Market Size by Instrumentation Technology & CAGR (2025-2032)

• Market Overview
• Spectroscopy
  • Mass Spectrometry
  • NMR Spectroscopy
  • CD Spectroscopy
• Chromatography
  • High-Performance Liquid Chromatography
  • Ion Chromatography
  • Affinity Chromatography
  • Supercritical Fluid Chromatography
• Electrophoresis
  • Gel Electrophoresis
  • Capillary Electrophoresis
• Protein Microarrays
  • Biochips
  • Lab-On-Chips
  • Protein Chips
  • Microarray Instruments
  • Integrated Systems
  • Microarray Scanners
  • Arrayers
• X-Ray Crystallography
• Surface Plasmon Resonance
• Protein Fractionation
• Other Instrumentation Technologies

Global Proteomics Market Size by Reagent & CAGR (2025-2032)

• Market Overview
• Immunoassay Reagents
• Spectroscopy Reagents
• Chromatography Reagents
• Protein Microarray Reagents
• X-Ray Crystallography Reagents
• Electrophoresis Reagents
• Protein Fractionation Reagents
• Other Reagents

Global Proteomics Market Size by Service & CAGR (2025-2032)

• Market Overview
• Core Proteomics Services
  • Protein Identification Services
  • Quantitative Proteomics Services
  • Protein Characterization Services
  • Protein Purification Services
  • Protein Separation Services
  • Protein Sequencing Services
  • Custom Assay Services
• Bioinformatics Services

Global Proteomics Market Size by Software & CAGR (2025-2032)

• Market Overview
• Bioinformatics Tools
• Bioinformatics Databases

Global Proteomics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Clinical Diagnostics
  • Cancer
  • Infectious Diseases
  • Diabetes
  • Neurological Disorders
  • Autoimmune Diseases
  • Cardiovascular Diseases
  • Other Clinical Diagnostic Applications
• Drug Discovery & Development
  • Target Discovery
  • Lead Identification
  • Lead Optimization
  • Preclinical Studies
• Other Applications

Global Proteomics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Biopharmaceutical Companies
• Academic And Research Institutes
• Hospitals
• Clinical Laboratories
• Other End Users

Global Proteomics Market Size & CAGR (2025-2032)

• North America (Instrumentation Technology, Reagent, Service, Software, Application, End User)
  • US
  • Canada
• Europe (Instrumentation Technology, Reagent, Service, Software, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Instrumentation Technology, Reagent, Service, Software, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Instrumentation Technology, Reagent, Service, Software, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Instrumentation Technology, Reagent, Service, Software, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare Life Sciences (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shinwa Chemical Industries (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nexelis (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteome Sciences (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyowa Kirin (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations